David Ege

David Ege

Chief Tech/Sci/R&D Officer at SERES THERAPEUTICS, INC.

Net worth: 57 165 $ as of 2024-03-30

50 year
Health Technology
Consumer Services
Commercial Services

Profile

David S.
Ege
is currently the Chief Technology Officer & Executive VP at Seres Therapeutics, Inc. Prior to this, he worked at Merck & Co., Inc. from 2003 to 2019, where he held the position of Executive Director-Vaccines & Biologics from 2015 to 2019.
He also worked as the President of Penn Biotech Group Healthcare Consulting.
Dr. Ege holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from Princeton University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-15 73,856 ( 0.05% ) 57 165 $ 2024-03-30

David Ege active positions

CompaniesPositionStart
SERES THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2020-10-21
All active positions of David Ege

Former positions of David Ege

CompaniesPositionEnd
MERCK & CO., INC. Corporate Officer/Principal 2019-05-31
President -
See the detail of David Ege's experience

Training of David Ege

University of Pennsylvania Doctorate Degree
Princeton University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Ege's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
MERCK & CO., INC.

Health Technology

SERES THERAPEUTICS, INC.

Health Technology

Private companies1

Commercial Services

See company connections